European Journal of Pharmacology
Overview
The European Journal of Pharmacology is a renowned scientific journal that publishes original research articles, reviews, and commentaries in the field of pharmacology. It covers a wide range of topics including drug discovery, mechanisms of action, therapeutic applications, and pharmacokinetics. With a focus on European research, this journal serves as a valuable resource for scientists, clinicians, and pharmaceutical professionals seeking to stay updated on the latest advancements in pharmacological sciences.
Details
Details
Abbr.
Eur J Pharmacol
Start
1967
End
Continuing
Frequency
24 no. a year, 2014-
p-ISSN
0014-2999
e-ISSN
1879-0712
Country
Netherlands
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 693
203
SJR / Ranks: 3461
1055
CiteScore / Ranks: 1928
8.70
Recent Articles
1.
Alotaibi G, Alkhammash A
Eur J Pharmacol
. 2025 Mar;
:177509.
PMID: 40089262
The endoplasmic reticulum (ER) plays a fundamental role in maintaining cellular homeostasis by ensuring proper protein folding, lipid metabolism, and calcium regulation. However, disruptions to ER function, known as ER...
2.
Wu Y, Yuan S, Wang Y, Zhang Y, Ye Z, Liu B, et al.
Eur J Pharmacol
. 2025 Mar;
:177433.
PMID: 40089261
This study aims to evaluate the effects of α-Bisabolol in the treatment of psoriasis both in vivo and in vitro, and to elucidate its mechanism of action. We used network...
3.
Singh R, Prerna , Bansal R
Eur J Pharmacol
. 2025 Mar;
:177467.
PMID: 40089260
Several recent literature reports indicate the strong neuroprotective potential of synthetic heterosteroids, still search for potent, safer and effective neuroprotective steroidal molecules continues. In the current study, a new series...
4.
Song Y, Xing X, Xiao Y, Luo Q, Gu B, Cheng Y, et al.
Eur J Pharmacol
. 2025 Mar;
:177471.
PMID: 40089259
Neonatal hypoxia-ischemia (HI) brain injury is considered a major cause of neonatal mortality and chronic disease morbidity worldwide. Despite its clinical importance, therapeutic options for HI injury remain limited. Here...
5.
Charles K, Yousuf A, Chua H, Matthews S, Harnett J, Hinton T
Eur J Pharmacol
. 2025 Mar;
:177508.
PMID: 40086582
Introduction: New modes of assessments are needed to evaluate of the authenticity of student learning in an artificial intelligence (AI) world. In mid-2023, we piloted a new assessment type; a...
6.
Zhi D, He X, Yang L, Xue Y, Liu Y, Yue D, et al.
Eur J Pharmacol
. 2025 Mar;
:177500.
PMID: 40086581
Royal jelly acid is a unique unsaturated fatty acid isolated from royal jelly. Recently, royal jelly acid was proposed to have potential therapeutic effects on hyperlipidemia. However, its effect on...
7.
Luo Y, Yao M, Wang R, Liao S, Yu J
Eur J Pharmacol
. 2025 Mar;
:177507.
PMID: 40086580
Ferroptosis contributes to neuronal destruction after ischemic stroke which may be improved by inhibiting BTB domain and CNC homologue 1 (BACH1), a recently recognized ferroptosis facilitator. Axon guidance molecule netrin-1...
8.
Zhao W, Wang X, Liu Y, Lu L, Ding Y, Zhang T
Eur J Pharmacol
. 2025 Mar;
:177506.
PMID: 40074140
Timosaponin AⅢ(TAⅢ), derived from the Chinese medicinal herb Anemarrhena asphodeloides Bunge, has been reported to have a range of pharmacological effects including improvement of learning and memory deficits, anti-tumor, hypoglycemic...
9.
Bao J, Li Z, Zhang D
Eur J Pharmacol
. 2025 Mar;
:177399.
PMID: 40064226
Lung cancer, a leading cause of cancer-related mortality globally, presents complex challenges in treatment and disease management. This review explores β-elemene, a sesquiterpene from Curcuma wenyujin, emphasising its pharmacological effects...
10.
Domingues C, Jarak I, Matos A, Veiga F, Vitorino C, Dourado M, et al.
Eur J Pharmacol
. 2025 Mar;
:177466.
PMID: 40064225
Oral squamous cell carcinoma (OSCC) is expected to rise ca. 40 % by 2040. Rosmarinic acid (RA) has been recognized for its anticancer properties, although its role in OSCC has...